- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Senate Finance Committee Chair Ron Wyden is considering substituting domestic reference pricing for House Democrats’ international reference pricing scheme in his bill to let Medicare negotiate drug prices, and the Oregon Democrat is considering including a drug appraisal entity that would help government negotiators by assessing what drugs are worth, according to lobbyists who support government negotiation.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us